Effect of Epinephrine/ Phenylephrine for Preventing the Postreperfusion Syndrome During Reperfusion in Liver Transplantation

NCT ID: NCT01080625

Last Updated: 2012-05-03

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-04-30

Study Completion Date

2011-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postreperfusion syndrome (PRS) is a relatively common phenomenon in patients undergoing liver transplantation which is characterized by an acute drop in blood pressure immediately after the prefusion is restored to the transplanted liver. We hypothesized that PRS would be prevented when phenylephrine or epinephrine is administered immediately prior to reperfusion in liver transplantation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypotension After Reperfusion in Liver Transplantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

phenylephrine

100 mcg of phenylephrine is administered at the time of reperfusion

Group Type EXPERIMENTAL

phenylephrine

Intervention Type DRUG

100 mcg of phenylephrine (volume 10 ml) iv at the time of reperfusion

epinephrine

10 mcg of epinephrine is administered iv at the time of reperfusion

Group Type EXPERIMENTAL

epinephrine

Intervention Type DRUG

10mcg of epinephrine (volume 10 ml) is administered iv at the time of reperfusion

control

10 ml of normal saline is administered at the time of reperfusion

Group Type PLACEBO_COMPARATOR

placebo control

Intervention Type DRUG

10ml of normal saline is administered at the time of reperfusion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

phenylephrine

100 mcg of phenylephrine (volume 10 ml) iv at the time of reperfusion

Intervention Type DRUG

epinephrine

10mcg of epinephrine (volume 10 ml) is administered iv at the time of reperfusion

Intervention Type DRUG

placebo control

10ml of normal saline is administered at the time of reperfusion

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- adults scheduled to undergo liver transplantation

Exclusion Criteria

\- pediatric liver transplantation
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chul-Woo Jung

Assistant professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Chul-Woo Jung, MD

Role: PRINCIPAL_INVESTIGATOR

Seoul National University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Hospital

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

References

Explore related publications, articles, or registry entries linked to this study.

Ryu HG, Jung CW, Lee HC, Cho YJ. Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation. Liver Transpl. 2012 Dec;18(12):1430-9. doi: 10.1002/lt.23511.

Reference Type DERIVED
PMID: 22821620 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CWJung_phen_epi_liver TPL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phenylephrine and Pulse Pressure Variability
NCT05011357 COMPLETED EARLY_PHASE1
Parameters of Cerebral Perfusion
NCT02806492 COMPLETED NA